KAPA   $0.9700000000000001  -3.00% Market Closed

Kairos Pharma Ltd
Total Cash 21.00K
totalCashPerShare 0.002
EBITDA -1.73M
Total Debt 783.00K
quickRatio 0.007
currentRatio 0.013
Total Revenue
debtToEquity
Revenue/Share
ROA -1.17654
ROE
grossProfits
freeCashflow -41.75K
operatingCashflow 25.00K
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 14.92M
forwardPE -5.826087
floatShares 3.34M
sharesOutstanding 12.84M
sharesShort 19.42K
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.69%
heldPercentInstitutions 0.0
Short Ratio help_outline 0.05%
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.251
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -2.01M
trailingEps -0.19%
forwardEps -0.23%
enterpriseToEbitda -8.62
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.02
institutionsCount 0
lastUpdated Nov. 2, 2024, 8:07 a.m.